descriptionPublicationkeyboard_double_arrow_right Article 01 Dec 2003Publisher:Centers for Disease Control and Prevention (CDC)Journal:Emerging Infectious Diseases, volume 9, pages 1,629-1,632 (issn: 1080-6040, eissn: 1080-6059,

Authors: Lawrence A. Cone; Joel Hirschberg; Millie M. Leung;

doi: 10.3201/eid0912.020646

pmid: 14720410

Actinomyces OdontolyticusBacteremia

- Summary
- Subjects
- Metrics

Abstract

We describe two immunosuppressed female patients with fever and Actinomyces odontolyticus bacteremia, a combination documented once previously in an immunocompetent male patient. The patients were treated with doxycycline and clindamycin; these drugs, with beta-lactams, are effective treatment for A. odontolyticus infections.

Related Organizations

University of California, Los Angeles
United States
Eisenhower Medical Center
United States
Kaiser Permanente
United States
Los Angeles Medical Center
United States

Keywords

R, Bacteremia, Infectious and parasitic diseases, RC109-216, opportunistic infections, Actinomyces odontolyticus, Middle Aged, Actinomycosis, actinomycosis, United States, Immunocompromised Host, Anti-Infective Agents, immunocompromised patients, Medicine, Actinomyces, Humans, Female, bacteremia, Aged

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	57
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average